Cliff Asness AQR Capital Management
Cliff Asness is a co-founder of AQR Capital Management, a leading quantitative investment firm spanning equities, alternatives, and factor strategies. He is known for academic-informed research on value, momentum, and other systematic premia, as well as candid market commentary. Asness’s work bridges academic finance and large-scale institutional portfolio management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$234M |
| 2 |
eBay
EBAY
|
+$223M |
| 3 |
Walt Disney
DIS
|
+$189M |
| 4 |
Humana
HUM
|
+$184M |
| 5 |
DXC Technology
DXC
|
+$172M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo
WFC
|
+$236M |
| 2 |
Citizens Financial Group
CFG
|
+$157M |
| 3 |
Applied Materials
AMAT
|
+$156M |
| 4 |
Huntsman Corp
HUN
|
+$154M |
| 5 |
STI
SunTrust Banks, Inc.
STI
|
+$151M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.97% |
| 2 | Technology | 16.56% |
| 3 | Industrials | 15.08% |
| 4 | Healthcare | 12.53% |
| 5 | Consumer Discretionary | 12.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1651
Willis Towers Watson
WTW
$32.6B
| $1.06M | ﹤0.01% |
7,285
+3,180
| +77% | +$444K |
|
1652
Federal Realty Investment Trust
FRT
$10.2B
| $1.05M | ﹤0.01% |
8,344
-11,761
| -58% | -$1.52M |
|
|
DO
1653
DELISTED
Diamond Offshore Drilling
DO
| $1.05M | ﹤0.01% |
97,273
-1,374,330
| -93% | -$18.3M |
|
|
NVRO
1654
DELISTED
NEVRO CORP.
NVRO
| $1.05M | ﹤0.01% |
14,117
+2,731
| +24% | +$219K |
|
1655
Andersons Inc
ANDE
$2.23B
| $1.05M | ﹤0.01% |
30,647
-480
| -2% | -$17.1K |
|
1656
Addus HomeCare
ADUS
$2.26B
| $1.04M | ﹤0.01% |
28,087
-1,002
| -3% | -$36K |
|
1657
First Horizon
FHN
$11.6B
| $1.04M | ﹤0.01% |
59,835
+993
| +2% | +$17.7K |
|
1658
Ironwood Pharmaceuticals
IRWD
$682M
| $1.04M | ﹤0.01% |
65,726
| – | – |
|
1659
Rayonier
RYN
$6.31B
| $1.04M | ﹤0.01% |
39,709
+17,774
| +81% | +$458K |
|
1660
SouthState Bank Corp
SSB
$10.4B
| $1.03M | ﹤0.01% |
12,081
+1,800
| +18% | +$155K |
|
1661
Regenxbio
RGNX
$531M
| $1.03M | ﹤0.01% |
+52,258
| New | +$1.01M |
|
1662
Integra LifeSciences
IART
$1.3B
| $1.03M | ﹤0.01% |
18,872
-10,044
| -35% | -$480K |
|
|
GWR
1663
DELISTED
Genesee & Wyoming Inc.
GWR
| $1.03M | ﹤0.01% |
15,047
| – | – |
|
|
AFSI
1664
DELISTED
AmTrust Financial Services, Inc.
AFSI
| $1.03M | ﹤0.01% |
67,989
-754,626
| -92% | -$11.1M |
|
1665
STAG Industrial
STAG
$7.14B
| $1.02M | ﹤0.01% |
37,045
-2,436
| -6% | -$65.2K |
|
1666
Independent Bank Corp
IBCP
$820M
| $1.01M | ﹤0.01% |
46,653
+3,225
| +7% | +$68.2K |
|
|
ELME
1667
Elme Communities
ELME
$149M
| $1.01M | ﹤0.01% |
31,718
-2,994
| -9% | -$96.2K |
|
|
ANAT
1668
DELISTED
American National Group, Inc. Common Stock
ANAT
| $1.01M | ﹤0.01% |
8,694
-13,400
| -61% | -$1.56M |
|
1669
Houlihan Lokey
HLI
$9.01B
| $1.01M | ﹤0.01% |
28,841
+12,719
| +79% | +$432K |
|
1670
Kaiser Aluminum
KALU
$2.49B
| $1.01M | ﹤0.01% |
11,363
-41,089
| -78% | -$3.41M |
|
1671
Waterstone Financial
WSBF
$381M
| $1M | ﹤0.01% |
53,220
-3,751
| -7% | -$70.6K |
|
1672
Progress Software
PRGS
$1.78B
| $1M | ﹤0.01% |
32,415
-13,153
| -29% | -$389K |
|
1673
Mercury Systems
MRCY
$5.38B
| $1M | ﹤0.01% |
23,776
+232
| +1% | +$9.12K |
|
1674
Energy Recovery
ERII
$398M
| $994K | ﹤0.01% |
119,869
-67,675
| -36% | -$542K |
|
1675
Chord Energy
CHRD
$7.91B
| $992K | ﹤0.01% |
123,247
-446,692
| -78% | -$4.89M |
|
Similar funds
Cliff Asness's Q2 2017 Portfolio in Review
As of Q2 2017, Cliff Asness held 2,306 positions worth $75.6B, up 0.44% from $75.2B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.
Cliff Asness's Q2 2017 filing shows 139 new, 928 increased, 1,013 reduced and 118 closed positions. Its largest new stake was DXC Technology: 2,594,054 shares worth $172M. The largest sale was Wells Fargo, an estimated $236M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 18% a quarter earlier, followed by Technology and Industrials.
- Cliff Asness's largest Q2 2017 buy was DXC Technology: 2,594,054 shares worth $172M.
- Cliff Asness added most to Gilead Sciences in Q2 2017, an estimated $234M increase.
- Cliff Asness's biggest Q2 2017 reduction was Wells Fargo, cutting an estimated $236M.
- Cliff Asness fully exited Computer Sciences in Q2 2017, selling an estimated $77.8M.
- Cliff Asness's ten largest holdings make up 9.2% of its $75.6B portfolio in Q2 2017.
- Cliff Asness opened 139 new positions and closed 118 in Q2 2017.
- Cliff Asness's portfolio value rose 0.44% quarter-over-quarter to $75.6B.
Based on AQR Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.